English | Español

University of California, San Francisco Medical Center
Patient Daily | Jan 13, 2026

UCSF Neurosurgery professor: 'Lots of evidence that 340B increases the cost of medications'

Trending
+ Pharmaceuticals
Patient Daily | Jan 30, 2026

Senate gridlock delays decision on rare disease priority review voucher program
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor